[
  {
    "ts": null,
    "headline": "Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day",
    "summary": "Boyd Gaming surges on strong earnings and growth plans, while Shoe Carnival struggles with sliding sales and weaker momentum.",
    "url": "https://finnhub.io/api/news?id=abe38108d466fa485c347af342f37d30be9996f4503123da50d1fd6e84606970",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756482660,
      "headline": "Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day",
      "id": 136573272,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Boyd Gaming surges on strong earnings and growth plans, while Shoe Carnival struggles with sliding sales and weaker momentum.",
      "url": "https://finnhub.io/api/news?id=abe38108d466fa485c347af342f37d30be9996f4503123da50d1fd6e84606970"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin",
    "summary": "AbbVie's strong financial results for the second quarter of 2025 were ensured by its two superstars, Rinvoq and Skyrizi. Click here to read my latest analysis.",
    "url": "https://finnhub.io/api/news?id=cd5b0e7f7073f7c6b99befc729473d98b794028f55711773ec7140c00fc76cbf",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756471054,
      "headline": "AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin",
      "id": 136571810,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1823932204/image_1823932204.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "AbbVie's strong financial results for the second quarter of 2025 were ensured by its two superstars, Rinvoq and Skyrizi. Click here to read my latest analysis.",
      "url": "https://finnhub.io/api/news?id=cd5b0e7f7073f7c6b99befc729473d98b794028f55711773ec7140c00fc76cbf"
    }
  },
  {
    "ts": null,
    "headline": "If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now",
    "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
    "url": "https://finnhub.io/api/news?id=cc00f476b770ab27ea7f6bdeb6bae58631954f5e1181a50203abab141ec9727a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756470604,
      "headline": "If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now",
      "id": 136569356,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
      "url": "https://finnhub.io/api/news?id=cc00f476b770ab27ea7f6bdeb6bae58631954f5e1181a50203abab141ec9727a"
    }
  },
  {
    "ts": null,
    "headline": "Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally",
    "summary": "We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Genmab A/S is one of them. Genmab A/S (NASDAQ:GMAB), based in Copenhagen, is a biotechnology company focused on developing antibody-based therapies for cancer and other serious diseases. It is among the cheap biotech stocks to buy. With over 45 […]",
    "url": "https://finnhub.io/api/news?id=ad5bc7c564406b5477e1440941587d0745b47f2a1ca89ff84b7b97be5ce1a334",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756458138,
      "headline": "Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally",
      "id": 136569139,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Genmab A/S is one of them. Genmab A/S (NASDAQ:GMAB), based in Copenhagen, is a biotechnology company focused on developing antibody-based therapies for cancer and other serious diseases. It is among the cheap biotech stocks to buy. With over 45 […]",
      "url": "https://finnhub.io/api/news?id=ad5bc7c564406b5477e1440941587d0745b47f2a1ca89ff84b7b97be5ce1a334"
    }
  }
]